supp.fit

Caprylic Acid: study protocols

13 study groups say how much Caprylic Acid participants took a day. These are the doses the studies gave. They are not a recommendation.

Caprylic Acid: what the research found →

Dose per serving from products

321 products in our catalogue print how much Caprylic Acid a serving holds.

Most common: 250 mg to 500 mg, 45% of 321 products.

Dose per servingProducts
50 mg or less
5
50 mg to 100 mg
18
100 mg to 250 mg
31
250 mg to 500 mg
144
500 mg to 1 g
31
1 g to 2.5 g
30
2.5 g to 5 g
19
5 g to 10 g
38
over 10 g
5

Dose per serving from research

9 study groups in 4 studies say how much Caprylic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mg to 250 mg, 44% of 9 study groups.

Daily doseStudy groups
100 mg or less
1
100 mg to 250 mg
4
250 mg to 500 mg
0
500 mg to 1 g
0
1 g to 2.5 g
1
2.5 g to 5 g
0
5 g to 10 g
0
10 g to 25 g
3

Commonly used together

8 of 13 study groups took Caprylic Acid with something else, but nothing that 3 or more different studies gave.

13 study groups

Study
Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study
2013 · octanoic acid (OA) · People with alcohol-responsive essential tremor
4 mg/kg1 day19
The response of the central and peripheral tremor component to octanoic acid in patients with essential tremor
2018 · octanoic acid (OA) · Adults aged 21 years or older with classic essential tremor
4 mg/kg1 day19
The Effect of Octanoic Acid on Essential Voice Tremor: A Double-Blind, Placebo-Controlled Study
2019 · octanoic acid condition · Adults with essential voice tremor; mean age 70.3 years, 2 males and 14 females in the analyzed sample
16 mg/kg3 weeks16
The Effect of Octanoic Acid on Essential Voice Tremor: A Double-Blind, Placebo-Controlled Study
2019 · octanoic acid condition, higher-dose exploratory day · Adults with essential voice tremor; exploratory higher-dose data were available for 14 participants
32 mg/kg1 day14
Supplementation of medium-chain triglycerides combined with docosahexaenoic acid improves cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial
2025 · MCT group · Chinese older adults with mild cognitive impairment
14 g1 year70
Supplementation of medium-chain triglycerides combined with docosahexaenoic acid improves cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial
2025 · MCT + DHA group · Chinese older adults with mild cognitive impairment
14 g1 year70
Eicosapentaenoic Acid and Medium-Chain Triacylglycerol Structured Lipid Supplementation Improves Muscular Endurance Exercise Performance and Reduces Muscle Fatigue in Young Healthy Male
2025 · EPA/MCT group · Healthy young men
1.11 g8 weeks10
The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans
2015 · 200 g carrots + 13.15 g C8-dietary oil · Healthy white men, mean age 24 years, mean BMI 22
13.2 g1 day12
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover
2004 · 0.15 mg daily sCT · Healthy postmenopausal women aged 55–85 years
200 mg90 days—
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover
2004 · 0.4 mg daily sCT · Healthy postmenopausal women aged 55–85 years
200 mg90 days—
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover
2004 · 1.0 mg daily sCT · Healthy postmenopausal women aged 55–85 years
200 mg90 days—
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover
2004 · 2.5 mg daily sCT · Healthy postmenopausal women aged 55–85 years
200 mg90 days—
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover
2004 · 1.0 mg intermittent sCT (every other day) · Healthy postmenopausal women aged 55–85 years
100 mg90 days—